Your browser doesn't support javascript.
loading
BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.
Warner, Evan; Herberts, Cameron; Fu, Simon; Yip, Steven; Wong, Amanda; Wang, Gang; Ritch, Elie; Murtha, Andrew J; Vandekerkhove, Gillian; Fonseca, Nicolette M; Angeles, Arkhjamil; Beigi, Arshia; Schönlau, Elena; Beja, Kevin; Annala, Matti; Khalaf, Daniel; Chi, Kim N; Wyatt, Alexander W.
Afiliação
  • Warner E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Herberts C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Fu S; BC Cancer, Vancouver Centre, Vancouver, British Columbia, Canada.
  • Yip S; Auckland City Hospital, Auckland, New Zealand.
  • Wong A; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.
  • Wang G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ritch E; Department of Pathology, BC Cancer, Vancouver, British Columbia, Canada.
  • Murtha AJ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Fonseca NM; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Angeles A; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Beigi A; BC Cancer, Vancouver Centre, Vancouver, British Columbia, Canada.
  • Schönlau E; BC Cancer, Vancouver Centre, Vancouver, British Columbia, Canada.
  • Beja K; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Annala M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Khalaf D; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Chi KN; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Finland.
  • Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Clin Cancer Res ; 27(6): 1650-1662, 2021 03 15.
Article em En | MEDLINE | ID: mdl-33414135
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Quinases Ciclina-Dependentes / Proteína BRCA2 / Neoplasias de Próstata Resistentes à Castração / Proteínas Mutadas de Ataxia Telangiectasia / DNA Tumoral Circulante / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Quinases Ciclina-Dependentes / Proteína BRCA2 / Neoplasias de Próstata Resistentes à Castração / Proteínas Mutadas de Ataxia Telangiectasia / DNA Tumoral Circulante / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article